APO Research
Talk to an analyst

APO RESEARCH · REPORT

RSV Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global RSV Vaccine Industry Growth and Trends Forecast to 2032

20 December 202594 pages

Choose your research edition.

Industry ResearchRSV Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal RSV Vaccine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal RSV Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RSV Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal RSV Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global RSV Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for RSV Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for RSV Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RSV Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RSV Vaccine include Nuance Pharma, Pfizer, GSK, Advaccine, Moderna, JNJ and Bavarian Nordic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global RSV Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The RSV Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global RSV Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to RSV Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global RSV Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

RSV Vaccine Market by Company

Nuance Pharma

Pfizer

GSK

Advaccine

Moderna

JNJ

Bavarian Nordic

RSV Vaccine Segment by Type

Being Developed

Preclinical

Clinical III

Clinical II

Clinical I

RSV Vaccine Segment by Application

Elderly Vaccine

Infant Vaccine

Others

RSV Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RSV Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RSV Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RSV Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of RSV Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of RSV Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Being Developed Table 2. Major Company of Preclinical Table 3. Major Company of Clinical III Table 4. Major Company of Clinical II Table 5. Major Company of Clinical I Table 6. Global RSV Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global RSV Vaccine Sales by Type (2021-2026) & (k units) Table 8. Global RSV Vaccine Sales Market Share in Volume by Type (2021-2026) Table 9. Global RSV Vaccine Sales by Type (2021-2026) & (US$ Million) Table 10. Global RSV Vaccine Sales Market Share in Value by Type (2021-2026) Table 11. Global RSV Vaccine Price by Type (2021-2026) & (US$/unit) Table 12. Global RSV Vaccine Sales by Type (2027-2032) & (k units) Table 13. Global RSV Vaccine Sales Market Share in Volume by Type (2027-2032) Table 14. Global RSV Vaccine Sales by Type (2027-2032) & (US$ Million) Table 15. Global RSV Vaccine Sales Market Share in Value by Type (2027-2032) Table 16. Global RSV Vaccine Price by Type (2027-2032) & (US$/unit) Table 17. North America RSV Vaccine Sales by Type (2021-2026) & (k units) Table 18. North America RSV Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Europe RSV Vaccine Sales by Type (2021-2026) & (k units) Table 20. Europe RSV Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific RSV Vaccine Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific RSV Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America RSV Vaccine Sales by Type (2021-2026) & (k units) Table 24. Latin America RSV Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa RSV Vaccine Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa RSV Vaccine Sales by Type (2021-2026) & (US$ Million) Table 27. RSV Vaccine Industry Trends Table 28. RSV Vaccine Industry Drivers Table 29. RSV Vaccine Industry Opportunities and Challenges Table 30. RSV Vaccine Industry Restraints Table 31. Global RSV Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global RSV Vaccine Revenue Market Share by Company (2021-2026) Table 33. Global RSV Vaccine Sales by Company (2021-2026) & (k units) Table 34. Global RSV Vaccine Sales Share by Company (2021-2026) Table 35. Global RSV Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 36. Global RSV Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global RSV Vaccine Major Company Production Sites and Headquarters Table 38. Global RSV Vaccine Company, Product Type & Application Table 39. Global RSV Vaccine Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global RSV Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global RSV Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global RSV Vaccine Sales by Region (2021-2026) & (k units) Table 44. Global RSV Vaccine Sales Market Share in Volume by Region (2021-2026) Table 45. Global RSV Vaccine Sales by Region (2021-2026) & (US$ Million) Table 46. Global RSV Vaccine Sales Market Share in Value by Region (2021-2026) Table 47. Global RSV Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global RSV Vaccine Sales by Region (2027-2032) & (k units) Table 49. Global RSV Vaccine Sales Market Share in Volume by Region (2027-2032) Table 50. Global RSV Vaccine Sales by Region (2027-2032) & (US$ Million) Table 51. Global RSV Vaccine Sales Market Share in Value by Region (2027-2032) Table 52. Global RSV Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global RSV Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global RSV Vaccine Sales by Application (2021-2026) & (k units) Table 55. Global RSV Vaccine Sales Market Share in Volume by Application (2021-2026) Table 56. Global RSV Vaccine Sales by Application (2021-2026) & (US$ Million) Table 57. Global RSV Vaccine Sales Market Share in Value by Application (2021-2026) Table 58. Global RSV Vaccine Price by Application (2021-2026) & (US$/unit) Table 59. Global RSV Vaccine Sales by Application (2027-2032) & (k units) Table 60. Global RSV Vaccine Sales Market Share in Volume by Application (2027-2032) Table 61. Global RSV Vaccine Sales by Application (2027-2032) & (US$ Million) Table 62. Global RSV Vaccine Sales Market Share in Value by Application (2027-2032) Table 63. Global RSV Vaccine Price by Application (2027-2032) & (US$/unit) Table 64. North America RSV Vaccine Sales by Application (2021-2026) & (k units) Table 65. North America RSV Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Europe RSV Vaccine Sales by Application (2021-2026) & (k units) Table 67. Europe RSV Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific RSV Vaccine Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific RSV Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America RSV Vaccine Sales by Application (2021-2026) & (k units) Table 71. Latin America RSV Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa RSV Vaccine Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa RSV Vaccine Sales by Application (2021-2026) & (US$ Million) Table 74. Nuance Pharma Company Information Table 75. Nuance Pharma Business Overview Table 76. Nuance Pharma RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Nuance Pharma RSV Vaccine Product Portfolio Table 78. Nuance Pharma Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Pfizer RSV Vaccine Product Portfolio Table 83. Pfizer Recent Development Table 84. GSK Company Information Table 85. GSK Business Overview Table 86. GSK RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. GSK RSV Vaccine Product Portfolio Table 88. GSK Recent Development Table 89. Advaccine Company Information Table 90. Advaccine Business Overview Table 91. Advaccine RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Advaccine RSV Vaccine Product Portfolio Table 93. Advaccine Recent Development Table 94. Moderna Company Information Table 95. Moderna Business Overview Table 96. Moderna RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Moderna RSV Vaccine Product Portfolio Table 98. Moderna Recent Development Table 99. JNJ Company Information Table 100. JNJ Business Overview Table 101. JNJ RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. JNJ RSV Vaccine Product Portfolio Table 103. JNJ Recent Development Table 104. Bavarian Nordic Company Information Table 105. Bavarian Nordic Business Overview Table 106. Bavarian Nordic RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Bavarian Nordic RSV Vaccine Product Portfolio Table 108. Bavarian Nordic Recent Development Table 109. North America RSV Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 110. North America RSV Vaccine Sales by Country (2021-2026) & (k units) Table 111. North America RSV Vaccine Sales Market Share by Country (2021-2026) Table 112. North America RSV Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 113. North America RSV Vaccine Sales Market Share Forecast by Country (2027-2032) Table 114. North America RSV Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America RSV Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 116. North America RSV Vaccine Market Share by Country (2021-2026) Table 117. North America RSV Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America RSV Vaccine Market Share Forecast by Country (2027-2032) Table 119. Europe RSV Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. Europe RSV Vaccine Sales by Country (2021-2026) & (k units) Table 121. Europe RSV Vaccine Sales Market Share by Country (2021-2026) Table 122. Europe RSV Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 123. Europe RSV Vaccine Sales Market Share Forecast by Country (2027-2032) Table 124. Europe RSV Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe RSV Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe RSV Vaccine Market Share by Country (2021-2026) Table 127. Europe RSV Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe RSV Vaccine Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific RSV Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific RSV Vaccine Sales by Country (2021-2026) & (k units) Table 131. Asia-Pacific RSV Vaccine Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific RSV Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 133. Asia-Pacific RSV Vaccine Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific RSV Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific RSV Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific RSV Vaccine Market Share by Country (2021-2026) Table 137. Asia-Pacific RSV Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific RSV Vaccine Market Share Forecast by Country (2027-2032) Table 139. Latin America RSV Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Latin America RSV Vaccine Sales by Country (2021-2026) & (k units) Table 141. Latin America RSV Vaccine Sales Market Share by Country (2021-2026) Table 142. Latin America RSV Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 143. Latin America RSV Vaccine Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America RSV Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America RSV Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America RSV Vaccine Market Share by Country (2021-2026) Table 147. Latin America RSV Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America RSV Vaccine Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa RSV Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa RSV Vaccine Sales by Country (2021-2026) & (k units) Table 151. Middle East and Africa RSV Vaccine Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa RSV Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 153. Middle East and Africa RSV Vaccine Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa RSV Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa RSV Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa RSV Vaccine Market Share by Country (2021-2026) Table 157. Middle East and Africa RSV Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa RSV Vaccine Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. RSV Vaccine Distributors List Table 162. RSV Vaccine Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. RSV Vaccine Image Figure 2. Global RSV Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RSV Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global RSV Vaccine Sales (2021-2032) & (k units) Figure 5. Being Developed Image Figure 6. Global Being Developed Sales YoY Growth (2021-2032) & (k units) Figure 7. Preclinical Image Figure 8. Global Preclinical Sales YoY Growth (2021-2032) & (k units) Figure 9. Clinical III Image Figure 10. Global Clinical III Sales YoY Growth (2021-2032) & (k units) Figure 11. Clinical II Image Figure 12. Global Clinical II Sales YoY Growth (2021-2032) & (k units) Figure 13. Clinical I Image Figure 14. Global Clinical I Sales YoY Growth (2021-2032) & (k units) Figure 15. Global RSV Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global RSV Vaccine Market Share by Type 2025 VS 2032 Figure 17. North America RSV Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. North America RSV Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Europe RSV Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Europe RSV Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific RSV Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific RSV Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Latin America RSV Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Latin America RSV Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa RSV Vaccine Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa RSV Vaccine Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 RSV Vaccine Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Elderly Vaccine Image Figure 30. Global Elderly Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 31. Infant Vaccine Image Figure 32. Global Infant Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global RSV Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global RSV Vaccine Market Share by Application 2025 VS 2032 Figure 37. North America RSV Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. North America RSV Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Europe RSV Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Europe RSV Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific RSV Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific RSV Vaccine Sales Market Share in Value by Application in 2025 Figure 43. Latin America RSV Vaccine Sales Market Share in Volume by Application in 2025 Figure 44. Latin America RSV Vaccine Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa RSV Vaccine Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa RSV Vaccine Sales Market Share in Value by Application in 2025 Figure 47. North America RSV Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America RSV Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America RSV Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America RSV Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe RSV Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe RSV Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe RSV Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe RSV Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific RSV Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific RSV Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific RSV Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific RSV Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America RSV Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America RSV Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America RSV Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America RSV Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa RSV Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa RSV Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa RSV Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa RSV Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. RSV Vaccine Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. RSV Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Being Developed
  • Preclinical
  • Clinical III
  • Clinical II
  • Clinical I
Applications
  • Elderly Vaccine
  • Infant Vaccine
  • Others
Companies covered
  • Nuance Pharma
  • Pfizer
  • GSK
  • Advaccine
  • Moderna
  • JNJ
  • Bavarian Nordic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global RSV Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global RSV Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 RSV Vaccine Market by Type
  6. 1.3.1 Being Developed
  7. 1.3.2 Preclinical
  8. 1.3.3 Clinical III
  9. 1.3.4 Clinical II
  10. 1.3.5 Clinical I
  11. 1.4 Global RSV Vaccine Market Size by Type
  12. 1.4.1 Global RSV Vaccine Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global RSV Vaccine Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global RSV Vaccine Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America RSV Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe RSV Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific RSV Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America RSV Vaccine Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa RSV Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 RSV Vaccine Industry Trends
  2. 2.2 RSV Vaccine Industry Drivers
  3. 2.3 RSV Vaccine Industry Opportunities and Challenges
  4. 2.4 RSV Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by RSV Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by RSV Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by RSV Vaccine Price (2021-2026)
  4. 3.4 Global RSV Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global RSV Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global RSV Vaccine Company, Product Type & Application
  7. 3.7 Global RSV Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global RSV Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 RSV Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 RSV Vaccine Tier 1, Tier 2, and Tier 3
4 RSV Vaccine Regional Status and Outlook
  1. 4.1 Global RSV Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global RSV Vaccine Historic Market Size by Region
  3. 4.2.1 Global RSV Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global RSV Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global RSV Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global RSV Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global RSV Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global RSV Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global RSV Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 RSV Vaccine by Application
  1. 5.1 RSV Vaccine Market by Application
  2. 5.1.1 Elderly Vaccine
  3. 5.1.2 Infant Vaccine
  4. 5.1.3 Others
  5. 5.2 Global RSV Vaccine Market Size by Application
  6. 5.2.1 Global RSV Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global RSV Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global RSV Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America RSV Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe RSV Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific RSV Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America RSV Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa RSV Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Nuance Pharma
  2. 6.1.1 Nuance Pharma Company Information
  3. 6.1.2 Nuance Pharma Business Overview
  4. 6.1.3 Nuance Pharma RSV Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Nuance Pharma RSV Vaccine Product Portfolio
  6. 6.1.5 Nuance Pharma Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer RSV Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer RSV Vaccine Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK RSV Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK RSV Vaccine Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Advaccine
  20. 6.4.1 Advaccine Company Information
  21. 6.4.2 Advaccine Business Overview
  22. 6.4.3 Advaccine RSV Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Advaccine RSV Vaccine Product Portfolio
  24. 6.4.5 Advaccine Recent Developments
  25. 6.5 Moderna
  26. 6.5.1 Moderna Company Information
  27. 6.5.2 Moderna Business Overview
  28. 6.5.3 Moderna RSV Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Moderna RSV Vaccine Product Portfolio
  30. 6.5.5 Moderna Recent Developments
  31. 6.6 JNJ
  32. 6.6.1 JNJ Company Information
  33. 6.6.2 JNJ Business Overview
  34. 6.6.3 JNJ RSV Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 JNJ RSV Vaccine Product Portfolio
  36. 6.6.5 JNJ Recent Developments
  37. 6.7 Bavarian Nordic
  38. 6.7.1 Bavarian Nordic Company Information
  39. 6.7.2 Bavarian Nordic Business Overview
  40. 6.7.3 Bavarian Nordic RSV Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bavarian Nordic RSV Vaccine Product Portfolio
  42. 6.7.5 Bavarian Nordic Recent Developments
7 North America by Country
  1. 7.1 North America RSV Vaccine Sales by Country
  2. 7.1.1 North America RSV Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America RSV Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America RSV Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America RSV Vaccine Market Size by Country
  6. 7.2.1 North America RSV Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America RSV Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America RSV Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe RSV Vaccine Sales by Country
  2. 8.1.1 Europe RSV Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe RSV Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe RSV Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe RSV Vaccine Market Size by Country
  6. 8.2.1 Europe RSV Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe RSV Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe RSV Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific RSV Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific RSV Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific RSV Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific RSV Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific RSV Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific RSV Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific RSV Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific RSV Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America RSV Vaccine Sales by Country
  2. 10.1.1 South America RSV Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America RSV Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America RSV Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America RSV Vaccine Market Size by Country
  6. 10.2.1 South America RSV Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America RSV Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America RSV Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa RSV Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa RSV Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa RSV Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa RSV Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa RSV Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa RSV Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa RSV Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa RSV Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 RSV Vaccine Value Chain Analysis
  2. 12.1.1 RSV Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 RSV Vaccine Production Mode & Process
  7. 12.2 RSV Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 RSV Vaccine Distributors
  10. 12.2.3 RSV Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst